Clinical Trials Browser

Adenocarcinoma, Stomach Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms, Stomach Neoplasms

Biliary Tract Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Colonic Neoplasms, Colorectal Neoplasms

Pancreatic Neoplasms

Biliary Tract Neoplasms

Neoplasm Metastasis, Gastrointestinal Stromal Tumors

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

Adenomatous Polyposis Coli, Polyps

Biliary Tract Neoplasms

Adenocarcinoma Of Esophagus, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Neoplasms, Stomach Neoplasms

Advanced Gastroenteropancreatic Neuroendocrine Tumor

Colorectal Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Neoplasm Metastasis, Pancreatic Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Hepatocellular

Colorectal Neoplasms

Biliary Tract Neoplasms

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Pancreatic Neoplasms

Adenocarcinoma Of Esophagus, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

Locally Advanced Gastric or Gastroesophageal Junction Cancer

Gastrointestinal Stromal Tumors

Colorectal Neoplasms

HER2-positive Gastric Cancer

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Carcinoma, Hepatocellular

Colorectal Neoplasms

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Adenocarcinoma, Neoplasms, Stomach Neoplasms

Pancreatic Neoplasms

Liver Neoplasms

Gastro-enteropancreatic neuroendocrine tumor, Lymphoma, Follicular

Carcinoma, Hepatocellular

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Hepatocellular

Clinical Trials

Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

FORTITUDE-101

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

TOPAZ-1

MK-4280A-007

KANDLELIT-012

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

DAWN-303

A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy Failure

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

MK-3475-C66

SERENTA

A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy and PD-1/PD-L1 Monoclonal Antibody Therapy(PANKU-BTC01)

HERIZON-GEA-01

An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.

Comparing Efficacy and Safety of Enlituo® Versus Erbitux® Plus FOLFOX in Locally Advanced/Metastatic Colorectal Cancer With RAS/BRAF Wild-type and MSS/pMMR Status.

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer

MAPKeeper 301

LEAP-012

A Study of HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal Cancer

DESTINY-BTC01

Beacon-BTC

RASolute 303

KEYNOTE 975

KUNLUN

Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer

A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)

Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

ARTEMIDE-HCC01

Comparison of A140 and Erbitux Combined With mfolfox6 to Evaluate Efficacy and Safety of First-line Treatment for Ras Wild-type mCRC

STAR-221

PRISM-1

OrigAMI-2

OrigAMI-3

A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

HARMONi-GI3

Spotlight

RASolute 304

SIERRA

NETTER-3

A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma

KRYSTAL-10

CodeBreak300

RASolute 302

KEYNOTE-937